On 18–20 February 2019, the World Health Organization (WHO) agreed on the recommended composition of the quadrivalent influenza vaccine for the northern hemisphere 2019–2020 influenza season: an A/Brisbane/02/2018 (H1N1)pdm09-like virus, an A(H3N2) virus component to be announced on 21 March 2019, a B/Colorado/06/2017-like virus (B/Victoria/2/87 lineage) and a B/Phuket/3073/2013-like virus (B/Yamagata/16/88 lineage).
The Carnival season will last from 1 to 9 March 2019. In Rio de Janeiro, Brazil, 1 million participants are expected, including many travellers from Europe
None of the European Union (EU) Member States could demonstrate that they reach the EU target of 75% influenza vaccination coverage for vulnerable groups, according to a new report from the European Centre for Disease Prevention and Control (ECDC).
On European Antibiotic Awareness Day, ECDC publishes the results of two point-prevalence surveys of healthcare-associated infections and antimicrobial use in hospitals and in long-term care facilities in the EU/EEA.
The Flu Awareness Week is marked across the WHO European Region every year in October. It aims to raise awareness of the importance of vaccination for people’s health and well-being and to increase the uptake of seasonal influenza vaccination of people with underlying risk factors.
Organized by:World Health Organization (WHO) - Regional office for Europe
Algerian health authorities reported over 160 cholera cases, with two fatalities, in five areas namely Algeirs, Bouira, Bilda, Medea and Tipaza in the northern part of the country.
Since the beginning of 2018 and as of 14 May, 2 980 autochthonous cases of dengue have been reported in Réunion. The main areas affected are in the western part of the island. The most prevalent serotype among dengue cases is DENV-2 and the main vector implicated in the outbreak is Aedes albopictus.
The main objective of the course was to strengthen capacity in EU Member States for control of healthcare-associated infections due to multidrug-resistant organisms (MDROs) in acute health care settings and to promote the broadest possible implementation of appropriate methods.
On 19-21 February 2018 the World Health Organization (WHO) agreed on the recommended composition of the trivalent influenza vaccine for the northern hemisphere 2018-2019 influenza season.